Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH.

Arch Gen Psychiatry. 1998 Jul;55(7):633-41.

PMID:
9672054
[PubMed - indexed for MEDLINE]
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
3.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
[PubMed - indexed for MEDLINE]
4.

Role of risperidone in children with autism spectrum disorder.

Chavez B, Chavez-Brown M, Rey JA.

Ann Pharmacother. 2006 May;40(5):909-16. Epub 2006 Mar 7. Review.

PMID:
16684811
[PubMed - indexed for MEDLINE]
5.

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, Freeman BJ, Martin A, McGough JJ, Cronin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, Volkmar FR, Votolato NA, Walson P.

Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):201-24. Review.

PMID:
10674197
[PubMed - indexed for MEDLINE]
6.

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Posey DJ, McDougle CJ.

Harv Rev Psychiatry. 2000 Jul-Aug;8(2):45-63. Review.

PMID:
10902094
[PubMed - indexed for MEDLINE]
7.

Pharmacotherapy of irritability in pervasive developmental disorders.

Stigler KA, McDougle CJ.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002. Review.

PMID:
18775367
[PubMed - indexed for MEDLINE]
8.

Risperidone: a potential treatment for autism.

Posey DJ, McDougle CJ.

Curr Opin Investig Drugs. 2002 Aug;3(8):1212-6. Review.

PMID:
12211417
[PubMed - indexed for MEDLINE]
9.

Off-label second generation antipsychotics for impulse regulation disorders: a review.

Scheltema Beduin A, de Haan L.

Psychopharmacol Bull. 2010;43(3):45-81. Review.

PMID:
21150846
[PubMed - indexed for MEDLINE]
10.

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

McDougle CJ, Stigler KA, Erickson CA, Posey DJ.

J Clin Psychiatry. 2008;69 Suppl 4:15-20. Review.

PMID:
18533764
[PubMed - indexed for MEDLINE]
11.

Developing drugs for core social and communication impairment in autism.

Posey DJ, Erickson CA, McDougle CJ.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):787-801, viii-ix. doi: 10.1016/j.chc.2008.06.010. Review.

PMID:
18775370
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pharmacotherapy to control behavioral symptoms in children with autism.

Doyle CA, McDougle CJ.

Expert Opin Pharmacother. 2012 Aug;13(11):1615-29. doi: 10.1517/14656566.2012.674110. Epub 2012 May 3. Review.

PMID:
22550944
[PubMed - indexed for MEDLINE]
13.

Autism and associated behavioral disorders: pharmacotherapeutic intervention.

Gilman JT, Tuchman RF.

Ann Pharmacother. 1995 Jan;29(1):47-56. Review.

PMID:
7711345
[PubMed - indexed for MEDLINE]
14.

Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part I.

Campbell M, Cueva JE.

J Am Acad Child Adolesc Psychiatry. 1995 Sep;34(9):1124-32. Review.

PMID:
7559305
[PubMed - indexed for MEDLINE]
15.

Use of medication in pervasive developmental disorders.

Sloman L.

Psychiatr Clin North Am. 1991 Mar;14(1):165-82. Review.

PMID:
1675463
[PubMed - indexed for MEDLINE]
16.

Managing irritability and aggression in autism spectrum disorders in children and adolescents.

Robb AS.

Dev Disabil Res Rev. 2010;16(3):258-64. doi: 10.1002/ddrr.118. Review.

PMID:
20981764
[PubMed - indexed for MEDLINE]
17.

Efficacy of risperidone in children with disruptive behavioural disorders.

Duhig MJ, Saha S, Scott JG.

J Paediatr Child Health. 2013 Jan;49(1):19-26. doi: 10.1111/j.1440-1754.2011.02200.x. Epub 2011 Nov 3. Review.

PMID:
22050179
[PubMed - indexed for MEDLINE]
18.

A systematic review of medical treatments for children with autism spectrum disorders.

McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-Vanderweele J.

Pediatrics. 2011 May;127(5):e1312-21. doi: 10.1542/peds.2011-0427. Epub 2011 Apr 4. Review.

PMID:
21464191
[PubMed - indexed for MEDLINE]
Free Article
19.

[Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone].

Leboyer M, Bouvard MP, Launay JM, Recasens C, Plumet MH, Waller-Perotte D, Tabuteau F, Bondoux D, Dugas M.

Encephale. 1993 Mar-Apr;19(2):95-102. Review. French.

PMID:
8275903
[PubMed - indexed for MEDLINE]
20.

Psychopharmacology of autism spectrum disorders.

Kaplan G, McCracken JT.

Pediatr Clin North Am. 2012 Feb;59(1):175-87, xii. doi: 10.1016/j.pcl.2011.10.005. Review.

PMID:
22284801
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk